FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098389 [Registered on: 03/12/2025] Trial Registered Prospectively
Last Modified On: 01/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical trial to study the effect of two types of drugs Fentanyl and Dexmedetomidine plus ketamine for postoperative pain for patients undergoing laparoscopic cholecystectomy  
Scientific Title of Study   A randomized comparative study to evaluate postoperative analgesia between opioid based and opioid free anesthesia in patients undergoing laparoscopic cholecystectomy  
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sudhir S 
Designation  Postgraduate 
Affiliation  M S Ramaiah Medical College 
Address  Department of Anaesthesiology M S Ramaiah Medical College Bangalore Karnataka 560054 India

Bangalore
KARNATAKA
560054
India 
Phone  9663474161  
Fax    
Email  drsudhirsherikar1997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Archana S 
Designation  Associate Professor 
Affiliation  M S Ramaiah Medical College 
Address  Department of Anaesthesiology M S Ramaiah Medical College Bangalore Karnataka 560054 India

Bangalore
KARNATAKA
560054
India 
Phone  9845121444  
Fax    
Email  archvinddoc@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Archana S 
Designation  Associate Professor 
Affiliation  M S Ramaiah Medical College 
Address  Department of Anaesthesiology M S Ramaiah Medical College Bangalore Karnataka 560054 India

Bangalore
KARNATAKA
560054
India 
Phone  9845121444  
Fax    
Email  archvinddoc@yahoo.co.in  
 
Source of Monetary or Material Support  
M S Ramaiah Medical College Bangalore, MSRIT Post New BEL Road Bangalore 560054 
 
Primary Sponsor  
Name  M S Ramaiah Medical College 
Address  MSRIT Post New BEL Road Bangalore 560054 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sudhir S  M S Ramaiah Medical College Hospital  Department of Anaesthesiology M S Ramaiah Medical College Bangalore Karnataka 560054 India
Bangalore
KARNATAKA 
9663474161

drsudhirsherikar1997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
M S Ramaiah Medical College Hospital Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K80||Cholelithiasis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  opioid based anaesthesia group (OBA)   In opioid based anaesthesia group (OBA) Fentanyl 2 µg/kg will be given and 0.5 µg/Kg Bolus will be given to maintain patient BP within 20% of pre operative measurement.  
Comparator Agent  Opioid free anesthesia group (OFA)  Loading dose of dexmedetomidine 0.5mcg/kg over 10 minutes, followed by dexmedetomidine infusion of 0.1 to 0.3mcg/kg/hour will be given to maintain the BP. Injection ketamine 0.5mg/kg was given before incision  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patients aged 18 to 60 years
2) American Society of Anaesthesiologists (ASA) classification II or III physical status with BMI of less than 30 kg/m2
3) Patients undergoing Laparoscopic Cholecystectomy
 
 
ExclusionCriteria 
Details  1. Patients with severe cardiovascular, renal, hepatic disorder
2. Patients with neuropsychiatric disorders
3. Patients with hemodynamic instability
4. Patients with drug allergy
5. Patients with history of malignant hyperthermia and Muscular dystrophy
6. Patients with muscular dystrophy
7. Patients with electrolyte imbalance
8. Patients with History of opioid use 1 month prior to surgery,
9. Patients with chronic opioid addiction

10. Patients with inability to comprehend visual analog scale (VAS)
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare time to first rescue analgesia between Opiod free Anaesthesia and Opiod based Anaesthesia groups.  Patients will be monitored for postoperative pain and any analgesic requirement 30 minutes after recovery, hourly for 2 hours and every 4 hourly for a period of 24 h.  
 
Secondary Outcome  
Outcome  TimePoints 
1. To Compare Total Rescue analgesic consumption in first 24hrs.
2. Postoperative pain scores will be assessed using the Visual Analogue Scale (VAS) at specific time intervals—1 hour, 6 hours, 12 hours, & 24 hours post-surgery.
3. Incidence of Post operative Nausea & Vomiting (PONV)
 
24 hours after surgery
 
Postoperative pain scores will be assessed using the Visual Analogue Scale (VAS) at specific time intervals—1 hour, 6 hours, 12 hours, & 24 hours post-surgery.  VAS score will be assessed at 1,6,12 & 24 hours after surgery. 
Incidence of post operative nausea vomiting   1 hour after surgery  
 
Target Sample Size   Total Sample Size="104"
Sample Size from India="104" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="6" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [drsudhirsherikar1997@gmail.com].

  6. For how long will this data be available start date provided 26-12-2027 and end date provided 26-12-2032?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Introduction

Laparoscopic cholecystectomy, though minimally invasive, is often associated with significant pain during the immediate post operative period due to peritoneal irritation, pneumoperitoneum, and tissue handling. Opioids remain the standard for peri-operative analgesia but are linked with several adverse effects such as respiratory depression, nausea, constipation, dependence, and delayed recovery.
Opioid free anaesthesia (OFA), which uses multimodal non opioid analgesics (e.g., dexmedetomidine, ketamine), aims to minimize opioid related complications while maintaining adequate analgesia. Evidence suggests OFA may reduce postoperative pain scores, opioid consumption, and PONV.


Need for the Study

Uncontrolled acute postoperative pain increases the risk of developing chronic postoperative pain. Reducing perioperative opioid use is essential to avoid long term opioid dependence and related adverse effects.
Although OFA has been studied, there is limited literature comparing postoperative analgesic outcomes between OFA and opioid based anaesthesia (OBA) specifically in laparoscopic cholecystectomy. This study aims to fill this gap by evaluating postoperative analgesia, rescue analgesic requirements, and PONV incidence.

Hypothesis

Opioid free anaesthesia provides:

Lower rescue analgesic consumption

Lower postoperative VAS pain scores

Earlier PACU discharge
compared to opioid based total intravenous anaesthesia.

Objectives

Primary Objective

To compare the time to first rescue analgesia between OFA and OBA groups.


Secondary Objectives

To compare total rescue analgesic consumption in the first 24 hours.

To evaluate postoperative VAS pain scores at 1, 6, 12, and 24 hours.

To assess the incidence of postoperative nausea and vomiting (PONV).


Methodology

Study Design

Randomised controlled study.

Participants

Patients aged 18 to 60 years undergoing elective laparoscopic cholecystectomy, ASA II or III, BMI less than 30 kg/m².

Exclusion Criteria

Severe systemic diseases, neuropsychiatric disorders, hemodynamic instability, drug allergy, history of opioid use or addiction, malignant hyperthermia, muscular dystrophy, electrolyte imbalance, or inability to comprehend VAS.

Randomisation

104 patients randomized into:

OFA group dexmedetomidine + ketamine

OBA group  fentanyl based anaesthesia


Procedure

Standardised general anaesthesia using TCI propofol with BIS monitoring. Postoperative pain assessed via VAS. Tramadol administered if VAS more than or equal to 4.

Outcome Measures

Time to first rescue analgesic

Total 24 hour rescue analgesic dose

VAS scores

PONV incidence


Statistical Analysis

Independent t test for comparing means

Chi-square test for categorical variables

Descriptive statistics for summary values


Expected Results

OFA is expected to prolong time to first rescue analgesia, reduce total opioid requirement, improve postoperative pain scores, and decrease PONV compared to OBA.
 
Close